Anagenex

Closed

Anagenex was founded in 2019, is headquartered in South San Francisco, United States, lists 11–50 employees, and has $37.2M in recorded funding across 2 rounds.

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$37.2M
Last Round
$30.0M Series AJun 2022
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Anagenex was a drug discovery company founded in 2019 and headquartered in South San Francisco, California, that combined DNA-encoded library technology with machine learning to identify small-molecule therapeutics via an iterative directed-evolution platform. Led by founder and CEO Nicolas Tilmans, the company closed a $30 million Series A round in 2022 led by Catalio Capital Management to advance its platform. In mid-2025 Anagenex's technology and team were acquired by another AI-driven drug discovery company backed by The Column Group, and its former domain now redirects to unrelated content.

Summary

Anagenex is an Artificial Intelligence company based in South San Francisco, United States, founded in 2019. It lists 11–50 employees. It has raised $37.2M in total across 2 rounds, most recently a $30.0M Series A round in Jun 2022. Investors include Lux Capital, Catalio Capital Management and Khosla Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJun 2022
$30.0M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026
Waymo

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...

Mountain View, United States1001–5000Artificial Intelligence, Autonomous Vehicles
Venture RoundTotal funding$29.6BFeb 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Anagenex on Indexed.vc
<a href="https://indexed.vc/companies/anagenex"><img src="https://indexed.vc/api/badge/company/anagenex" alt="Anagenex on Indexed.vc" width="260" height="76" /></a>